| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 185 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 185 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 185 |
| 3 | LEVONORGESTREL | 69 |
| 4 | FLUDARABINE PHOSPHATE | 66 |
| 5 | BUSULFAN | 53 |
| 6 | DOXORUBICIN | 47 |
| 7 | ETOPOSIDE | 45 |
| 8 | ADALIMUMAB | 43 |
| 9 | METHOTREXATE SODIUM | 40 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 13 | 0.0909 |
| 1 | PROCAINAMIDE HYDROCHLORIDE | 17 | 0.0688 |
| 2 | FRANKINCENSE | 1 | 0.0164 |
| 3 | CHLORPROMAZINE HYDROCHLORIDE | 11 | 0.0115 |
| 4 | IOBENGUANE I-123 | 1 | 0.0088 |
| 5 | METHSUXIMIDE | 1 | 0.0055 |
| 6 | NIROGACESTAT | 4 | 0.0043 |
| 7 | HYDRALAZINE HYDROCHLORIDE | 10 | 0.0037 |
| 8 | DINUTUXIMAB | 3 | 0.0035 |
| 9 | METHYLDOPA | 17 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 215 |
| 1 | Progestin [EPC] | 75 |
| 2 | Progestin-containing Intrauterine System [EPC] | 69 |
| 3 | Corticosteroid [EPC] | 59 |
| 4 | Estrogen [EPC] | 45 |
| 5 | Topoisomerase Inhibitor [EPC] | 45 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 34 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 33 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 31 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gamma Secretase Inhibitor [EPC] | 4 | 0.0043 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 2 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 3 | Actinomycin [EPC] | 5 | 0.0023 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 5 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 6 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 7 | Allylamine Antifungal [EPC] | 7 | 0.0010 |
| 8 | Alkylating Drug [EPC] | 215 | 0.0009 |
| 9 | Provitamin D2 Compound [EPC] | 23 | 0.0008 |